Veterinary Medicines

CANIGEN DHА2PPi /LR

Authorised
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Rabies virus, strain VP12, Inactivated
Download as PDF

Product identification

Medicine name:
CANIGEN DHА2PPi /LR
Active substance:
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Rabies virus, strain VP12, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle, Live
    3.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    4.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, strain Cornell 780916, Live
    5.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Manhattan, Live
    5.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    8.33
    80% Protective Dose
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    8.33
    80% Protective Dose
    /
    1.00
    Dose
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2296
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/02/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."